Insider Trading March 13, 2026

Saba Capital Trims Stake in BlackRock ESG Trust, Realizes $2.39M From Share Sales

Ten-percent holder Saba Capital disposed of 164,336 ECAT shares across two days as the trust trades near its 52-week low and yields 23%

By Derek Hwang ECAT
Saba Capital Trims Stake in BlackRock ESG Trust, Realizes $2.39M From Share Sales
ECAT

Saba Capital Management, L.P., a roughly 10% shareholder of BlackRock ESG Capital Allocation Term Trust (ECAT), sold 164,336 shares on March 11-12, 2026, generating $2.39 million in proceeds. The transactions were disclosed in a Form 4 signed by Zachary Gindes on behalf of Saba and by Boaz Weinstein. ECAT is trading at $14.14, close to a 52-week low of $13.35, and offers a 23% dividend yield. InvestingPro rates ECAT's financial health as "GREAT" and notes the trust pays a significant dividend.

Key Points

  • Saba Capital Management, L.P. sold a total of 164,336 ECAT shares on March 11 and 12, 2026, realizing $2.39 million.
  • Sales occurred at prices between $14.52 and $14.67 per share; after the transactions Saba’s holdings stood at 22,485,085 shares.
  • ECAT is trading at $14.14, near its 52-week low of $13.35, and the trust offers a 23% dividend yield; InvestingPro reports a "GREAT" financial health score.

Saba Capital Management, L.P. executed a two-day disposal of common shares in BlackRock ESG Capital Allocation Term Trust (EXCHANGE:ECAT), according to a regulatory filing. The firm, which holds about 10% of the trust, sold a combined 164,336 shares on March 11 and March 12, 2026, producing total proceeds of $2.39 million.

The reported sale prices ranged from $14.52 to $14.67 per share. On March 11, Saba Capital sold 54,395 shares at $14.67 each. That transaction lowered the firm’s stake to 22,595,026 shares. The next day, March 12, the firm sold an additional 109,941 shares at $14.52 apiece, reducing its holdings to 22,485,085 shares.

The transactions were made public in a Form 4 filing with the Securities and Exchange Commission. The Form 4 was signed by Zachary Gindes on behalf of Saba Capital Management, L.P., and by Boaz Weinstein.

At the time of the filing, the trust was trading at $14.14, which places the market price close to its 52-week low of $13.35. The trust also offers a substantial dividend yield of 23%.

InvestingPro, which provides additional proprietary metrics, assigns ECAT a financial health score of "GREAT" and notes that the trust pays a significant dividend to shareholders.


Context and market signals

The filing documents the specific share counts and prices for each day of sales and records the resulting reductions in Saba Capital’s holdings. The trust’s market price, recent trading levels and advertised dividend yield are included in the disclosure and in the InvestingPro summary referenced in the filing.

All transaction and holding figures above are taken from the Form 4 filing and related data reported alongside the SEC disclosure.

Risks

  • Market risk: ECAT is trading close to its 52-week low, indicating downside price pressure for investors in the trust.
  • Insider disposition: The reduction in Saba Capital’s stake may raise questions about shareholder positioning, although the filing does not state motives.
  • Information limitation: The filing documents the transactions and signatures but does not provide explanation for the sales, leaving motive and timing unclear.

More from Insider Trading

Vicor Chairman Disposes $8.37 Million in Stock as Shares Rally Mar 13, 2026 First Financial Bankshares Director Buys $43,770 Worth of Stock as Company Announces Leadership Moves Mar 13, 2026 Mid Penn Bancorp Director Purchases $79,930 in MPB Shares as Bank Reports Strong Q4 and Recent Deals Mar 13, 2026 Peoples Bancorp Director Disposes $59,446 in Shares; Bank Posts Modest Beat on EPS Mar 13, 2026 Evergy CTO Disposes $200,532 in Shares as Stock Trades Near 52-Week High Mar 13, 2026